Invention Grant
- Patent Title: Substituted pyrazole compounds as RORgammaT inhibitors and uses thereof
-
Application No.: US15549465Application Date: 2016-02-11
-
Publication No.: US10221142B2Publication Date: 2019-03-05
- Inventor: Blair T. Lapointe , Peter H. Fuller , Hakan Gunaydin , Kun Liu , Nunzio Sciammetta , Benjamin Wesley Trotter , Hongjun Zhang , Kenneth J. Barr , John K. F. Maclean , Danielle F. Molinari , Vladimir Simov
- Applicant: Merck Sharp & Dohme Corp.
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme Corp.
- Current Assignee: Merck Sharp & Dohme Corp.
- Current Assignee Address: US NJ Rahway
- Agency: Dechert LLP
- International Application: PCT/US2016/017566 WO 20160211
- International Announcement: WO2016/130818 WO 20160818
- Main IPC: C07D231/56
- IPC: C07D231/56 ; C07D487/04 ; A61K45/06 ; A61K31/416 ; C07D471/04 ; C07D491/052 ; C07D491/107 ; C07D495/04 ; C07D403/12 ; C07D487/14 ; C07D405/12 ; C07D413/06 ; C07D487/06 ; C07D513/04
Abstract:
The present invention relates to compounds according to Formula (I-1) and pharmaceutically acceptable salts thereof. Such compounds can be used in the treatment of RORgammaT-mediated diseases or conditions.
Public/Granted literature
- US20180016239A1 SUBSTITUTED PYRAZOLE COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF Public/Granted day:2018-01-18
Information query
